Singapore · 
Who invested in Hummingbird Bioscience?
Hummingbird Bioscience's investors include GNTech Venture Capital, Polaris Partners, Novo Holdings, EDBI and Seeds Capital, and 1 more on record.
20202021
$19MSeries B$125MSeries C
Singapore · Series C startup
Who invested in Hummingbird Bioscience
Funding summaryUpdated 26 Oct 2026
$144Mraised across 2 rounds since 2019, from 2 sources
$19MSeries B$125MSeries C
- Latest round
- Series C, $125MMay 2021
- Step-upi
- 6.6×
- Investors
- 6 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $19M Dec 2019
- Biggest round
- $125M Series C · May 2021
- Between rounds
- 17 months from the last two
The rounds
- May 2021
- Dec 2019
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series B2019Series C2021
GNTech Venture CapitalL
Polaris Partners
Novo Holdings
EDBI
Seeds CapitalHeritas Capital
GNTech Venture CapitalLPolaris PartnersNovo HoldingsEDBISeeds CapitalHeritas CapitalEveryone who backed them
Heritas CapitalPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 7 firms list Hummingbird Bioscience as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Hummingbird Bioscience
How much has Hummingbird Bioscience raised?
Hummingbird Bioscience has raised $144M across 2 rounds since 2019.
When did Hummingbird Bioscience last raise?
Hummingbird Bioscience's most recent round was a Series C of $125M in May 2021.
What was Hummingbird Bioscience's biggest round?
Its most recent round, $125M in May 2021, is also its largest on record.
Who backed Hummingbird Bioscience first?
Hummingbird Bioscience's first round on record, in Dec 2019, was backed by GNTech Venture Capital, Seeds Capital and Heritas Capital.
What stage is Hummingbird Bioscience at?
Hummingbird Bioscience's latest named round is a Series C, in May 2021.
Where is Hummingbird Bioscience based?
Hummingbird Bioscience is based in Singapore.
Who led Hummingbird Bioscience's rounds?
GNTech Venture Capital led the Series B in 2019.
Companies like Hummingbird Bioscience
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.